MarketPeel
Insider Trading Intelligence
GB

Garen G. Bohlin

KPTI
DIRECTOR · KARYOPHARM THERAPEUTICS INC. · CIK 0001254705
FILING MIX · LIFETIME83%/17%
BUYS
19
SELLS
4
TOTAL VALUE
$1.65M
COMPANIES
2
ACTIVE SINCE
May 2020
HOLDINGS NOW
89,517
AVG SELL PX
$33.43
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Garen G. Bohlin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+1.06%-0.13%+1.19%-2.17%
14d4+50.00%+3.80%-1.28%+7.92%+3.79%
30d4+75.00%-1.04%+0.44%-1.48%-3.73%
60d4(1 pending)+66.67%-8.46%+3.38%-11.85%-11.89%
90d4(1 pending)+0.00%-12.21%+3.76%-15.97%-9.03%
180d4(1 pending)+66.67%-5.87%+13.86%-19.73%-18.48%
1y4(1 pending)+33.33%-27.00%+13.07%-40.07%-26.39%
2y4(1 pending)+0.00%-42.47%+32.02%-74.48%-68.16%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KPTI · 18,517 shares · as of May 21, 2026
017,25034,50051,75069,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 4 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
15,50818,517May 21, 2026May 26, 2026View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
8,74171,000May 14, 2026May 18, 2026View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
8,7000May 11, 2026May 13, 2026View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
8,700$16.49$143.5K70,959May 11, 2026May 13, 2026View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
8,700$37.18$323.5K62,259May 11, 2026May 13, 2026View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
4,6004,600May 28, 2025May 29, 2025View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
9,79162,259May 15, 2025May 19, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
69,00069,000May 29, 2024May 30, 2024View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
7,69352,468May 16, 2024May 16, 2024View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
28,985$5.73$166.1K73,760May 14, 2024May 16, 2024View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
28,985$32.30$936.3K44,775May 14, 2024May 16, 2024View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
28,9850May 14, 2024May 16, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
41,140$1.22$50.0K45,140Sep 12, 2023Sep 12, 2023View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
34,00034,000May 24, 2023May 25, 2023View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
9,79244,775May 18, 2023May 19, 2023View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
23,90023,900May 19, 2022May 20, 2022View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
14,03534,983May 19, 2022May 23, 2022View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
23,90023,900May 21, 2021May 21, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
9,94120,948May 20, 2021May 24, 2021View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
4,000$7.82$31.3K4,000May 6, 2021May 10, 2021View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
16,40016,400May 21, 2020May 26, 2020View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
4,04711,007May 20, 2020May 22, 2020View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
8,0958,095May 20, 2020May 22, 2020View →
Other insiders · KPTI
Loading peer insiders…
About this filer
CIK 0001254705
ROLE
Director
PRIMARY
KPTI
COMPANIES
2
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001254705DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback